SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL).
Angela
A
Philippen
Susanne
S
Diener
Thorsten
T
Zenz
Hartmut
H
Döhner
Stephan
S
Stilgenbauer
Daniel
D
Mertens
D001483:Base Sequence; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics*; D009363:Neoplasm Proteins / Q000235:genetics; D017354:Point Mutation; D020641:Polymorphism, Single Nucleotide; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D000072377:Syk Kinase
D047908:Intracellular Signaling Peptides and Proteins; D009363:Neoplasm Proteins; D011505:Protein-Tyrosine Kinases; C000606896:SYK protein, human; D000072377:Syk Kinase